Surface Oncology Inc

NASDAQ:SURF  
8.58
+0.50 (+6.19%)
Earnings Announcements

Surface Oncology Reports Financial Results And Corporate Highlights For Third Quarter 2020

Published: 11/10/2020 11:27 GMT
Surface Oncology Inc (SURF) - Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2020.
Q3 Loss per Share $0.39.
Q3 Earnings per Share Estimate $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.39

Next Quarter Revenue Guidance is expected to be $1.67 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.